Why is RB still getting the majority of the blame for ICGs shortcomings? RB hasn't been the MD for more than six months now and since then the share price has been in continuous decline and we've only got 2 assay results to show for it. Has Adam really been an improvement?
I'm just saying that the lack of urgency hasn't improved since RB stepped down as MD.
Chairman's update - "We are the duck swimming in the pond right now, from the surface it looks steady and calm but underwater we are paddling rapidly"
From the surface paddling and not paddling look remarkably similar are we even paddling at all?
2023 - the year for ICG, page-22
-
- There are more pages in this discussion • 1,668 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ICG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.438M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $6.216K | 879.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1120813 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2814049 | 3 |
View Market Depth
| Last trade - 10.56am 19/06/2024 (20 minute delay) ? |
| ICG (ASX) Chart |